Company Newsletters (All)
Company Newsletters (All)
Date | File Name |
---|---|
23 March 2018 | Nature.com scientific report – Stevenson et al on Cantrixil |
06 December 2016 | Novogen Enrols First Patient into Phase I Study of Cantrixil |
11 August 2016 | Novogen submits IND Application to the FDA for Cantrixil |
24 November 2015 | Novogen engages CRO for Cantrixil Phase 1 Clinical Trial |
12 November 2015 | Patent for Cantrixil and Trilexium Accepted in Australia |